Stephen Tapscott

Dr. Stephen Tapscott is a Professor in the Human Biology Division and Clinical Research Division at Fred Hutchinson Cancer Center, and a Professor of Neurology at the University of Washington School of Medicine. His research focuses on understanding the molecular mechanisms of gene regulation in normal development and disease, with particular emphasis on muscular dystrophy and cancer.

Dr. Tapscott received his MD and PhD from the University of Pennsylvania in 1982, and his BA from Hampshire College in 1975. His dual training in medicine and basic science has positioned him at the intersection of clinical and translational research.

Dr. Tapscott's research program investigates how genes are turned on and off during normal development and how this process goes awry in diseases. His lab is particularly known for groundbreaking work on facioscapulohumeral dystrophy (FSHD), where his team discovered that proteins normally present in early development are erroneously activated in muscle cells of FSHD patients. This discovery has opened new avenues for understanding and potentially treating this form of muscular dystrophy. The Tapscott Lab also studies rhabdomyosarcoma, a type of muscle cancer, and explores gene and cell therapy approaches for muscular disorders. His work spans multiple disciplines including molecular biology, genetics, immunology, and cancer research, with particular emphasis on gene regulation, chromatin biology, and translational applications.

Analysis of Dr. Tapscott's recent publications reveals a strong focus on the DUX4 gene and its role in FSHD and cancer. His work demonstrates a progression from basic molecular mechanisms toward potential therapeutic applications, with significant contributions to understanding how DUX4 activates early embryonic programs in adult tissues, interacts with the immune system, and contributes to disease pathogenesis.

Dr. Tapscott leads the Tapscott Lab at Fred Hutch, which studies gene transcription in a chromatin context in normal development and disease. His team employs a range of molecular, cellular, and genomic approaches to understand the fundamental mechanisms of gene regulation and their implications for human disease. He maintains active collaborations with clinicians and researchers working on muscular dystrophies and related disorders, facilitating the translation of basic discoveries into potential therapeutic approaches.